Skip to main content
. Author manuscript; available in PMC: 2009 Nov 1.
Published in final edited form as: Int J Infect Dis. 2008 Jun 2;12(6):635–644. doi: 10.1016/j.ijid.2008.03.012

Table 2.

Prevalence of drug resistance to first line antituberculosis at 4 sentinel sites in Georgia, 2001-2004

Resistance Profile All Cases New Cases Retreatment
Cases
Unknown
Treatment
History
N % N % N % N %
Total number of strains
tested

931

100.0

534

100.0

388

100.0

9

100.0
I. Any drug resistance a 596 64.0 258 48.3 331 85.3 7 77.8
Isoniazid (INH) 442 47.5 159 29.8 280 72.2 3 33.3
Rifampin (RIF) 287 30.8 66 12.4 220 56.7 1 11.1
Streptomycin (SM) 490 52.6 199 37.3 284 73.2 7 77.8
Ethambutol (EMB) 210 22.7 56 10.5 154 39.7 0 0
II. Monoresistance b 188 20.2 126 23.6 59 15.2 3 33.3
INH only 59 6.3 39 7.3 20 5.2 0 0
RIF only 7 0.8 3 0.6 4 1.0 0 0
SM only 108 11.6 75 14.0 30 7.7 3 33.3
EMB only 14 1.5 9 1.7 5 1.3 0 0
III. MDR-TBa 262 28.1 56 10.5 206 53.1 0 0
INH + RIF 15 1.6 6 1.1 9 2.3 0 0
INH + RIF + EMB 6 0.6 0 0 6 1.6 0 0
INH + RIF + SM 98 10.5 26 4.9 72 18.5 0 0
INH + RIF + SM + EMB 143 15.4 24 4.5 119 30.7 0 0
IV. Polyresistance c 146 15.7 76 14.2 66 17.0 4 44.4
INH + EMB 2 0.2 1 0.2 1 0.3 0 0
INH + SM 86 9.2 48 9.0 35 9.0 3 33.3
INH + EMB + SM 33 3.5 15 2.8 18 4.6 0 0
RIF + EMB 3 0.3 1 0.2 2 0.5 0 0
RIF + SM 13 1.4 5 0.9 7 1.8 1 11.1
RIF + EMB + SM 2 0.2 1 0.2 1 0.3 0 0
EMB + SM 7 0.7 5 0.9 2 0.5 0 0
Number of drugs
resistant to:
Susceptible to 4 drugs 335 36.0 276 51.7 57 14.7 2 22.2
Resistance to 1 drug 188 20.2 126 23.6 59 15.2 3 33.3
Resistance to 2 drugs 126 13.5 66 12.3 56 14.4 4 44.4
Resistance to 3 drugs 139 14.9 42 7.9 97 25.0 0 0
Resistance to 4 drugs 143 15.4 24 4.5 119 30.7 0 0

INH=isoniazid; RIF=rifampin; EMB=ethambutol; SM=streptomycin MDR-TB=multidrug-resistant tuberculosis (resistance to at least both isoniazid and rifampin) Polyresistance=resistance to two or more drugs but not both isoniazid and rifampin

a

p<0.001 in Chi-square test for comparison of prevalence of resistance pattern among retreatment cases to that among new cases

b

p=0.002 in Chi-square test for comparison of prevalence of resistance pattern among retreatment cases to that among new cases

c

p=0.25 in Chi-square test for comparison of prevalence of resistance pattern among retreatment cases to that among new cases.